Iberogast

Iberogast, the active ingredient in Iberogast, is a herbal presented as a liquid oral drops for oral use. It treats functional gastrointestinal disorders such as functional dyspepsia and irritable bowel syndrome in adults.

GNH USA supplies Iberogast as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iberogast is used to manage functional gastrointestinal disorders by relieving dysmotility and discomfort. - Functional dyspepsia: reduces upper abdominal pain, early satiety and bloating. - Irritable bowel syndrome: eases abdominal cramping, irregular bowel habits and urgency. - Bloating: diminishes abdominal distension and gas sensation. - Nausea: lessens the feeling of nausea associated with functional GI conditions.

Iberogast may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Taste alteration: mild bitter or herbal aftertaste. - Mild gastrointestinal upset: occasional nausea or abdominal discomfort. - Allergic skin reaction: localized rash or itching at the oral mucosa. - Headache: transient mild headache.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention. - Liver enzyme elevation: rare hepatotoxicity manifested by increased transaminases. - Severe skin reaction: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Use Iberogast with caution and follow medical guidance. - Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: insufficient data; consider risk/benefit. - Children: not recommended for use in children under 12 years. - Drug interactions: monitor concomitant use of CYP‑modulating herbs. - Medical conditions: caution in patients with known hypersensitivity to any component. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Iberogast may interact with other medicines; review patient medication list.

Major Interactions (Avoid): - Cytochrome P450 inhibitors: may increase exposure to herbal constituents. - Anticoagulants (e.g., warfarin): potential increased bleeding risk. - Immunosuppressants: possible alteration of drug metabolism.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may affect gastric pH and absorption. - Antidiarrheal agents (e.g., loperamide): additive antispasmodic effect. - Other herbal products: risk of additive hepatotoxicity.